EUA
Labcorp SARS-CoV-2 & Influenza A/B Assay
FDA Emergency Use Authorization · Laboratory Corporation of America (Labcorp) · Jul 28, 2022
Key facts
| Product | Labcorp SARS-CoV-2 & Influenza A/B Assay |
|---|---|
| Company | Laboratory Corporation of America (Labcorp) |
| Product type | Real-time RT-PCR, Multi-analyte, Home Collection, Multiple Targets |
| Date | Jul 28, 2022 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: